Inhibitory Antibodies
-
BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans. -
F1001 Anti-CD4 Antibody (Ibalizumab)Summary: Anti-CD4 Antibody (Ibalizumab) -
F1002 Anti-FOLR1/FRA Antibody (Farletuzumab)Summary: Anti-FOLR1/FRA Antibody (Farletuzumab) -
F1003 Anti-CD4 Antibody (Semzuvolimab)Summary: Anti-CD4 Antibody (Semzuvolimab) -
F1004 Anti-TNFSF13/APRIL/CD256 Antibody (Sibeprenlimab)Summary: Anti-TNFSF13/APRIL/CD256 Antibody (Sibeprenlimab) -
F1005 Anti-HBsAg Antibody (OST 577)Summary: Anti-HBsAg Antibody (OST 577) -
F1006 Anti-RSV-F Antibody (Motavizumab)Summary: Anti-RSV-F Antibody (Motavizumab) -
F1007 Anti-RSV-F Antibody (Palivizumab)Summary: Anti-RSV-F Antibody (Palivizumab) -
F1008 Anti-CSF2/GM-CSF Antibody (Lenzilumab)Summary: Anti-CSF2/GM-CSF Antibody (Lenzilumab) -
F1009 Anti-MASP2 Antibody (Narsoplimab)Summary: Anti-MASP2 Antibody (Narsoplimab)

